IDEAYA Biosciences (IDYA) Interest & Investment Income (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Interest & Investment Income of -$2.8 million for Q1 2026, down 457.18% on a YoY basis from $773000.0 in Q1 2025, and down 1384.19% sequentially from $215000.0 in Q4 2025.
IDEAYA Biosciences (IDYA) Interest & Investment Income (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 8 years of Interest & Investment Income data on file, last reported at -$2.8 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 457.18% year-over-year to -$2.8 million; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 182.89% YoY), and the FY2025 full-year result was $1.5 million, up 482.0% from the prior year.
- Interest & Investment Income declined to -$2.8 million in Q1 2026, from $215000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.3 million in Q3 2024 to a low of -$3.0 million in Q4 2024.
- A 5-year average of $12823.5 and a median of $215000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income plunged 29785.71% in 2022 and soared 1124.24% in 2024, its largest moves.
- Tracing IDYA's Interest & Investment Income over 5 years: stood at $1.1 million in 2022, then grew by 16.0% to $1.3 million in 2023, then sank by 330.49% to -$3.0 million in 2024, then soared by 107.11% to $215000.0 in 2025, then plunged by 1384.19% to -$2.8 million in 2026.
- Business Quant data shows IDYA's Interest & Investment Income at -$2.8 million in Q1 2026, $215000.0 in Q4 2025, and $531000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | IDEAYA Biosciences | 3.26 Bn | 2.59 Bn | - | -2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.76 Mn |
| Dec 31, 2025 | 215,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | -64,000.00 |
| Mar 31, 2025 | 773,000.00 |
| Dec 31, 2024 | -3.02 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | -493,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 429,000.00 |
| Jun 30, 2023 | 226,000.00 |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | -373,000.00 |
| Jun 30, 2022 | -825,000.00 |
| Mar 31, 2022 | -2.09 Mn |
| Dec 31, 2021 | -662,000.00 |
| Sep 30, 2021 | -46,000.00 |
| Jun 30, 2021 | -3,000.00 |